NZ Peptides
Tirzepatide Research Peptide - Dual GIP/GLP-1 Agonist 10mg Purity > 99%
Tirzepatide Research Peptide - Dual GIP/GLP-1 Agonist 10mg Purity > 99%
Couldn't load pickup availability
Tirzepatide: Dual GIP/GLP-1 Receptor Agonist for Advanced Metabolic Research
Novel dual incretin receptor agonist for investigating glucose homeostasis, appetite regulation, and metabolic disease mechanisms. Purity >99% with fast NZ shipping.
🔬 Research Applications Overview
Tirzepatide is a first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that represents a significant advancement in metabolic research. This synthetic peptide is utilized in laboratory investigations of dual incretin pathway activation, glycemic control mechanisms, and energy balance regulation in experimental models.
💥 Key Research Benefits
| Research Area | Application |
| ⚡ Dual Incretin Activation | Unique tool for investigating synergistic GIP and GLP-1 receptor pathway interactions and their combined metabolic effects |
| 🔥 Glucose Homeostasis | Essential for research into insulin secretion, glucose-dependent mechanisms, and glycemic control pathways in pre-clinical models |
| 💪 Appetite Regulation | Investigated for its effects on satiety signaling, food intake regulation, and central nervous system appetite pathways |
| 🧬 Energy Balance | Critical for understanding energy expenditure, lipid metabolism, and body composition changes in controlled research settings |
| 🛡️ Metabolic Disease Models | Valuable for investigating type 2 diabetes, obesity, and metabolic syndrome mechanisms in laboratory investigations |
✅ Why Choose NZ Peptides' Tirzepatide?
- Guaranteed Purity >99%: Every batch is tested and provided as sterile, lyophilized powder
- Authentic Dual Agonist Structure: Precise 39-amino acid sequence ensures maximum bioactivity and predictable research results
- Research Grade Quality: Manufactured to the highest laboratory standards for reliable experimental outcomes
- Fast NZ Shipping: Quick dispatch across New Zealand and Australia
- Certificate of Analysis: Full documentation available upon request
📋 Product Specifications
- Peptide: Tirzepatide (LY3298176)
- Sequence: 39 amino acids (GIP-based with C20 fatty diacid modification)
- Purity: >99%
- Vial Size: 10mg
- Form: Sterile lyophilized powder
- Storage: Refrigerate for up to 1 year maximum; reconstitute as needed
❓ Frequently Asked Questions
Q: What makes Tirzepatide unique compared to other incretin-based peptides?
A: Tirzepatide is the first dual GIP/GLP-1 receptor agonist, combining activation of both incretin pathways in a single molecule. This dual mechanism provides a unique research tool for investigating synergistic metabolic effects that cannot be achieved with single-receptor agonists.
Q: What research areas is Tirzepatide most commonly used for?
A: Tirzepatide is primarily utilized in research investigating type 2 diabetes mechanisms, obesity and weight regulation pathways, dual incretin receptor pharmacology, cardiovascular-metabolic interactions, and glucose-dependent insulin secretion in laboratory models.
Q: How should this product be stored?
A: Store lyophilized powder in refrigerator for up to 1 year maximum. Once reconstituted, store in refrigerator and use within 4-5 weeks maximum per your research protocol.
Q: Is this product approved for human use?
A:
⚠️ Disclaimer: Our products are sold strictly for non-human, in-vitro (laboratory) research purposes only and are not approved for human or veterinary consumption, therapy, or diagnosis. All information provided is for educational and scientific reference exclusively.
